Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal, non-opioid drug candidate for ...

A new survey highlights a growing “clinical interpretation gap” as patients increasingly rely on digital tools to understand their health data. LOS ANGELES, CA ...

Kamada Ltd (KMDA) reports a 12% revenue increase and outlines future growth strategies amid market challenges.

Real-world pilot finds agentic AI delivers $10M in cost savings and 2,000 hours per year in time savings, while ...

LA CROSSE, WI, UNITED STATES, March 11, 2026 /EINPresswire.com/ — The City of La Crosse, in partnership with Revby LLC, has introduced Launch & Grow: Finance ...

Model-based Definition views/captures stored in numerous CAD formats are easily accessed from the part tree of all four MBD Utility products. These views always have a saved 3D orientation and usually ...

Leading facility management company raises record donation supporting SEALs’ transition of elite military experience ...